1-(3-Fluoro-benzyl)-[1,4]diazepane hydrochloride, 95.0%, 500mg

Isopropyl palmitate, min. 90%, for synthesis, 500 ml, plastic packaging.

2-methyl-4-(4-piperidinyl)pyrimidine dihydrochloride, 95.0%, 1g

5-amino-3-(trifluoromethyl)-1,2-thiazole-4-carbonitrile, 95.0%, 1g

1-(4-Aminopiperidin-1-yl)-2-methoxyethanone hydrochloride, 95.0%, 1g

2-(Hydroxymethyl)-6-methylphenol, 95%, 5g

3-Ethynyl-imidazo[1,2-a]pyrazine, 97%, 1g

Niobium silicide 99% 50 g

2-Fluoro-5-methylpyridine-4-carboxaldehyde, 98%, 100mg

2-Bromo-5-chloro-4-methoxypyridine, 97%, 5g

5-BROMO-2-NAPHTHOL, 95%, 1g

2-Oxo-2,3-dihydro-1H-benzimidazole-5-carbonitrile, 95.0%, 5g

(R)-Endo-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-3-phenylpropanoate, 95.0%, 250mg